8-K - PharmaCyte Biotech Inc. | Modeledge

PharmaCyte Biotech Inc.

Filing type: 8-K
Filing date: Aug 17, 2025
Updated: Aug 18, 2025 · 7:20 AM

Filing

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Reg. FD

Exhibits

EX-3.1FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES C CONVERTIBLE PREFERRED STOCK EX-4.1FORM OF WARRANT EX-10.1FORM OF PURCHASE AGREEMENT EX-10.2FORM OF REGISTRATION RIGHTS AGREEMENT EX-10.3ENGAGEMENT LETTER, DATED AUGUST 17, 2025 BY AND BETWEEN PHARMACYTE BIOTECH, INC. AND GP NURMENKARI INC.EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Reg. FD GRAPHICGraphic